T h e ne w e ngl a nd jou r na l o f m e dicine T he adverse health effects associated with long-term exposure to air pollution are well documented. 1, 2 Studies suggest that fine particles (particles with a mass median aerodynamic diameter of less than 2.5 μm [PM 2.5 ]) are a public health concern, 3 with exposure linked to decreased life expectancy. [4] [5] [6] Longterm exposure to ozone has also been associated with reduced survival in several recent studies, although evidence is sparse. 4, [7] [8] [9] Studies with large cohorts have investigated the relationship between long-term exposures to PM 2.5 and ozone and mortality 4, [9] [10] [11] [12] [13] ; others have estimated the health effects of fine particles at low concentrations (e.g., below 12 μg per cubic meter for PM 2.5 ). [14] [15] [16] [17] [18] However, most of these studies have included populations whose socioeconomic status is higher than the national average and who reside in well-monitored urban areas. Consequently, these studies provide limited information on the health effects of long-term exposure to low levels of air pollution in smaller cities and rural areas or among minorities or persons with low socioeconomic status.
To address these gaps in knowledge, we conducted a nationwide cohort study involving all Medicare beneficiaries from 2000 through 2012, a population of 61 million, with 460 million person-years of follow-up. We used a survival analysis to estimate the risk of death from any cause associated with long-term exposure (yearly average) to PM 2.5 concentrations lower than the current annual National Ambient Air Quality Standard (NAAQS) of 12 μg per cubic meter and to ozone concentrations below 50 parts per billion (ppb). Subgroup analyses were conducted to identify populations with a higher or lower level of pollution-associated risk of death from any cause.
Me thods

Mortality Data
We obtained the Medicare beneficiary denominator file from the Centers for Medicare and Medicaid Services, which contains information on all persons in the United States covered by Medicare and more than 96% of the population 65 years of age or older. We constructed an open cohort consisting of all beneficiaries in this age group in the continental United States from 2000 through 2012, with all-cause mortality as the outcome. For each beneficiary, we extracted the date of death (up to December 31, 2012) , age at year of Medicare entry, year of entry, sex, race, ZIP Code of residence, and Medicaid eligibility (a proxy for low socioeconomic status). Persons who were alive on January 1 of the year following their enrollment in Medicare were entered into the open cohort for the survival analysis. Follow-up periods were defined according to calendar years.
Assessment of Exposure to Air Pollution
Ambient levels of ozone and PM 2.5 were estimated and validated on the basis of previously published prediction models. 19, 20 Briefly, we used an artificial neural network that incorporated satellite-based measurements, simulation outputs from a chemical transport model, land-use terms, meteorologic data, and other data to predict daily concentrations of PM 2.5 and ozone at unmonitored locations. We fit the neural network with monitoring data from the Environmental Protection Agency (EPA) Air Quality System (AQS) (in which there are 1928 monitoring stations for PM 2.5 and 1877 monitoring stations for ozone). We then predicted daily PM 2.5 and ozone concentrations for nationwide grids that were 1 km by 1 km. Cross-validation indicated that predictions were good across the entire study area. The coefficients of determination (R 2 ) for PM 2.5 and ozone were 0.83 and 0.80, respectively; the mean square errors between the target and forecasting values for PM 2.5 and ozone were 1.29 μg per cubic meter and 2.91 ppb, respectively. Data on daily air temperature and relative humidity were retrieved from North American Regional Reanalysis with grids that were approximately 32 km by 32 km; data were averaged annually. 21 For each calendar year during which a person was at risk of death, we assigned to that person a value for the annual average PM 2.5 concentration, a value for average ozone level during the warm season (April 1 through September 30), and values for annual average temperature and humidity according to the ZIP Code of the person's residence. The warm-season ozone concentration was used to compare our results with those of previous studies. 10 In this study, "ozone concentration" refers to the average concentration during the warm season, unless specified otherwise.
As part of a sensitivity analysis, we also obtained data on PM 2.5 and ozone concentrations from the EPA AQS and matched that data with To identify populations at a higher or lower pollution-associated risk of death from any cause, we refit the same two-pollutant Cox model for some subgroups (e.g., male vs. female, white vs. black, and Medicaid eligible vs. Medicaid ineligible). To estimate the concentration-response function of air pollution and mortality, we fit a log-linear model with a thin-plate spline of both PM 2.5 and ozone and controlled for all the individual and ecologic variables used in our main analysis model (Section 7 in the Supplementary Appendix). To examine the robustness of our results, we conducted sensitivity analyses and compared the extent to which estimates of risk changed with respect to differences in confounding adjustment and estimation approaches (Sections S2 through S4 in the Supplementary Appendix).
Data on some important individual-level covariates were not available for the Medicare cohort, including data on smoking status, bodymass index (BMI), and income. We obtained data from the Medicare Current Beneficiary Survey (MCBS), a representative subsample of Medicare enrollees (133,964 records and 57,154 enrollees for the period 2000 through 2012), with individuallevel data on smoking, BMI, income, and many other variables collected by means of telephone survey. Using MCBS data, we investigated how the lack of adjustment for these risk factors could have affected our calculated risk estimates in the Medicare cohort (Section 5 in the Supplementary Appendix). The computations in this article were run on the Odyssey cluster, which is supported by the FAS Division of Science, Research Computing Group, and on the Research Computing Environment, which is supported by the Institute for Quantitative Social Science in the Faculty of Arts and Sciences, both at Harvard University. We used R software, version 3.3.2 (R Project for Statistical Computing), and SAS software, version 9.4 (SAS Institute).
R esult s
Cohort Analyses
The full cohort included 60,925,443 persons living in 39,716 different ZIP Codes with 460,310,521 person-years of follow-up. The median follow-up was 7 years. The total number of deaths was 22,567,924. There were 11,908,888 deaths and 247,682,367 person-years of follow-up when the PM 2.5 concentration was below 12 μg per cubic meter and 17,470,128 deaths and 353,831,836 person-years of follow-up when the ozone concentration was below 50 ppb. These data provided excellent power to estimate the risk of death at air-pollution levels below the current annual NAAQS for PM 2.5 and at low concentrations for ozone (Table 1) .
Annual average PM 2.5 concentrations across the continental United States during the study period ranged from 6.21 to 15.64 μg per cubic meter (5th and 95th percentiles, respectively), and the warm-season average ozone concentrations ranged from 36.27 to 55.86 ppb (5th and 95th percentiles, respectively). The highest PM 2.5 concentrations were in California and the eastern and southeastern United States. The Mountain region and California had the highest ozone concentrations; the eastern states had lower ozone concentrations (Fig. 1) .
T h e ne w e ngl a nd jou r na l o f m e dicine * Summary statistics were calculated separately for persons residing in ZIP Codes where average ozone levels were below or above 50 ppb and where PM 2.5 levels were below or above 12 μg per cubic meter. The value 12 μg per cubic meter was chosen as the current annual National Ambient Air Quality Standard (NAAQS) (e.g., the "safe" level) for PM 2.5 . BMI denotes body-mass index (the weight in kilograms divided by the square of the height in meters) and ppb parts per billion. † The number for total person-years of follow-up indicates the sum of individual units of time that the persons in the study population were at risk of death from 2000 through 2012. ‡ The average values for air pollution levels and for ecologic and meteorologic variables were computed by averaging values over all ZIP Codes from 2000 through 2012. § Data on race and ethnic group were obtained from Medicare beneficiary files. ¶ The variable for ambulatory visits refers to the average annual percentage of Medicare enrollees who had at least one ambulatory visit to a primary care physician. In a two-pollutant analysis, each increase of 10 μg per cubic meter in annual exposure to PM 2.5 (estimated independently of ozone) and each increase of 10 ppb in warm-season exposure to ozone (estimated independently of PM 2.5 ) was associated with an increase in all-cause mortality of 7.3% (95% confidence interval [CI], 7.1 to 7.5) and 1.1% (95% CI, 1.0 to 1.2), respectively. Estimates of risk based on predictive, ZIPCode-specific assessments of exposure were slightly higher than those provided by the nearest data-monitoring site (Table 2 ). When we restricted the PM 2.5 and ozone analyses to locationyears with low concentrations, we continued to see significant associations between exposure and mortality ( Table 2) . Analysis of the MCBS T h e ne w e ngl a nd jou r na l o f m e dicine subsample provided strong evidence that smoking and income are not likely to be confounders because they do not have a significant association with PM 2.5 or ozone (Section 5 in the Supplementary Appendix).
Subgroup Analyses
Subgroup analyses revealed that men; black, Asian, and Hispanic persons; and persons who were eligible for Medicaid (i.e., those who had low socioeconomic status) had a higher estimated risk of death from any cause in association with PM 2.5 exposure than the general population. The risk of death associated with ozone exposure was higher among white, Medicaid-eligible persons and was significantly below 1 in some racial subgroups (Fig. 2) . Among black persons, the effect estimate for PM 2.5 was three times as high as that for the overall population (Table S3 in the Supplementary Appendix). Overall, the risk of death associated with ozone exposure was smaller and somewhat less robust than that associated with PM 2.5 exposure. We also detected a small but significant interaction between ozone exposure and PM 2.5 exposure (Table S8 in the Supplementary Appendix). Our thin-plate-spline fit indicated a relationship between PM 2.5 , ozone, and all-cause mortality that was almost linear, with no signal of threshold down to 5 μg per cubic meter and 30 ppb, respectively (Fig. 3 , and 
Discussion
This study involving an open cohort of all persons receiving Medicare, including those from small cities and rural areas, showed that longterm exposures to PM 2.5 and ozone were associated with an increased risk of death, even at levels below the current annual NAAQS for PM 2.5 . Furthermore, the study showed that black men and persons eligible to receive Medicaid had a much higher risk of death associated with exposure to air pollution than other subgroups. These findings suggest that lowering the annual NAAQS may produce important public health benefits overall, especially among self-identified racial minorities and people with low income.
The strengths of this study include the assessment of exposure with high spatial and temporal resolution, the use of a cohort of almost 61 million Medicare beneficiaries across the entire continental United States followed for up to 13 consecutive years, and the ability to perform subgroup analyses of the health effects of air pollution on groups of disadvantaged persons. However, Medicare claims do not include extensive individual-level data on behavioral risk fac- * Hazard ratios and 95% confidence intervals were calculated on the basis of an increase of 10 μg per cubic meter in exposure to PM 2.5 and an increase of 10 ppb in exposure to ozone. † Daily average monitoring data on PM 2.5 and ozone were obtained from the Environmental Protection Agency Air Quality System. Daily ozone concentrations were averaged from April 1 through September 30 for the computation of warmseason averages. Data on PM 2.5 and ozone levels were obtained from the nearest monitoring site within 50 km. If there was more than one monitoring site within 50 km, the nearest site was chosen. Persons who lived more than 50 km from a monitoring site were excluded. ‡ For the single-pollutant analysis, model specifications were the same as those used in the main analysis, except that ozone was not included in the model when the main effect of PM 2.5 was estimated and PM 2.5 was not included in the model when the main effect of ozone was estimated. tors, such as smoking and income, which could be important confounders. Still, our analysis of the MCBS subsample (Table S6 in the Supplementary Appendix) increased our level of confidence that the inability to adjust for these individuallevel risk factors in the Medicare cohort did not lead to biased results (Section 5 in the Supplementary Appendix). In another study, we analyzed a similar Medicare subsample with detailed individual-level data on smoking, BMI, and many other potential confounders linked to Medicare claims. 23 In that analysis, we found that for mortality and hospitalization, the risks of exposure to PM 2.5 were not sensitive to the additional control of individual-level variables that were not available in the whole Medicare population. Hazard ratios and 95% confidence intervals are shown for an increase of 10 μg per cubic meter in PM 2.5 and an increase of 10 parts per billion (ppb) in ozone. Subgroup analyses were conducted by first restricting the population (e.g., considering only male enrollees). The same two-pollutant analysis (the main analysis) was then applied to each subgroup. Numeric results are presented in Tables S3 and S4 Overall population
Overall population
T h e ne w e ngl a nd jou r na l o f m e dicine
We also found that our results were robust when we excluded individual and ecologic covariates from the main analysis ( Fig. S2 and Table S2 in the Supplementary Appendix), when we stratified age at entry into 3-year and 4-year categories rather than the 5 years used in the main analysis (Fig. S3 in the Supplementary Appendix), when we varied the estimation procedure (by means of a generalized estimating equation as opposed to mixed effects) (Tables S3  and S4 in the Supplementary Appendix), and when we used different types of statistical software (R, version 3.3.2, vs. SAS, version 9.4). Finally, we found that our results were consistent with others published in the literature (Section 6 in the Supplementary Appendix). 5, 17, [24] [25] [26] [27] [28] There was a significant association between PM 2.5 exposure and mortality when the analysis was restricted to concentrations below 12 μg per cubic meter, with a steeper slope below that level. This association indicated that the healthbenefit-per-unit decrease in the concentration of PM 2.5 is larger for PM 2.5 concentrations that are below the current annual NAAQS than the health benefit of decreases in PM 2.5 concentrations that are above that level. Similar, steeper concentration-response curves at low concentrations have been observed in previous studies. 29 Moreover, we found no evidence of a threshold value -the concentration at which PM 2.5 exposure does not affect mortality -at concentrations as low as approximately 5 μg per cubic meter (Fig. 3) ; this finding is similar to those of other studies. 18, 30 The current ozone standard for daily exposure is 70 ppb; there is no annual or seasonal standard. Our results strengthen the argument for establishing seasonal or annual standards. Moreover, whereas time-series studies have shown the short-term effects of ozone exposure, our results indicate that there are larger effect sizes for longer-term ozone exposure, including in locations where ozone concentrations never exceed 70 ppb. Unlike the American Cancer Society Cancer Prevention Study II, 9,10 our study reported a linear connection between ozone concentration and mortality. This finding is probably the result of the interaction between PM 2.5 and ozone (Section 7 in the Supplementary Appendix). The significant, linear relationship between seasonal ozone levels and all-cause mortality indicates that current risk assessments, [31] [32] [33] which incorporate only the acute effects of ozone exposure on deaths each day from respiratory mortality, may be substantially underestimating the contribution of ozone exposure to the total burden of disease.
The enormous sample size in this study, which includes the entire Medicare cohort, allowed for unprecedented accuracy in the estimation of risks among racial minorities and disadvantaged subgroups. The estimate of effect size for PM 2.5 expo- A log-linear model with a thin-plate spline was fit for both PM 2.5 and ozone, and the shape of the concentration-response surface was estimated (Fig. S8 in the Supplementary Appendix). The concentration-response curve in Panel A was plotted for an ozone concentration equal to 45 ppb. The concentration-response curve in Panel B was plotted for a PM 2.5 concentration equal to 10 μg per cubic meter. These estimated curves were plotted at the 5th and 95th percentiles of the concentrations of PM 2.5 and ozone, respectively. The complete concentration-response three-dimensional surface is plotted in Fig. S8 sure was greatest among male, black, and Medicaid-eligible persons. We also estimated risks in subgroups of persons who were eligible for Medicaid and in whites and blacks alone to ascertain whether the effect modifications according to race and Medicaid status were independent. We found that black persons who were not eligible for Medicaid (e.g., because of higher income) continued to have an increased risk of death from exposure to PM 2.5 ( Fig. S4 in the Supplementary Appendix). In addition, we found that there was a difference in the health effects of PM 2.5 exposure between urban and rural populations, a finding that may be due to compositional differences in the particulates (Table S3 Supplementary Appendix).
Although the Medicare cohort includes only the population of persons 65 years of age or older, two thirds of all deaths in the United States occur in people in that age group. Although our exposure models had excellent out-of-sample predictive power on held-out monitors, they do have limitations. Error in exposure assessment remains an issue in this type of analysis and could attenuate effect estimates for air pollution. 34 The overall association between air pollution and human health has been well documented since the publication of the landmark Harvard Six Cities Study in 1993. 25 With air pollution declining, it is critical to estimate the health effects of low levels of air pollution -below the current NAAQS -to determine whether these levels are adequate to minimize the risk of death. Since the Clean Air Act requires the EPA to set air-quality standards that protect sensitive populations, it is also important to focus more effort on estimating effect sizes in potentially sensitive populations in order to inform regulatory policy going forward.
